These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 18577931)
1. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics]. Popov MIu Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931 [TBL] [Abstract][Full Text] [Related]
2. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients. Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855 [TBL] [Abstract][Full Text] [Related]
3. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group. Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505 [TBL] [Abstract][Full Text] [Related]
4. Diurnal variations of extrapyramidal symptoms induced by haloperidol in schizophrenic subjects. Torner C; Herrera-Estrella M; Gutiérrez JA; Aguilar-Roblero R Int J Neuropsychopharmacol; 2003 Sep; 6(3):243-6. PubMed ID: 12974990 [TBL] [Abstract][Full Text] [Related]
5. [Acute-onset extrapyramidal syndromes caused by drugs]. Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295 [TBL] [Abstract][Full Text] [Related]
6. Aripiprazole: new drug. Just another neuroleptic. Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069 [TBL] [Abstract][Full Text] [Related]
7. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia. Tamrakar SM; Nepal MK; Koirala NR; Sharma VD; Gurung CK; Adhikari SR Kathmandu Univ Med J (KUMJ); 2006; 4(2):152-60. PubMed ID: 18603890 [TBL] [Abstract][Full Text] [Related]
8. [Effect of nifedipine on the effectiveness of antipsychotic therapy in schizophrenia]. Dzhuga NP; Kozlovskiĭ VL Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(8):32-5. PubMed ID: 19738566 [TBL] [Abstract][Full Text] [Related]
9. Risperidone in treatment-refractory schizophrenia. Wirshing DA; Marshall BD; Green MF; Mintz J; Marder SR; Wirshing WC Am J Psychiatry; 1999 Sep; 156(9):1374-9. PubMed ID: 10484947 [TBL] [Abstract][Full Text] [Related]
10. [A differential approach to the improvement of prevention and correction of neuroleptic side extrapyramidal disorders with pantogam activ in patients with schizophrenia]. Tiganov AS; Panteleeva GP; Abramova LI; Bologov PV; Kananovich PS; Omel'chenko MA; Nikiforova IY Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(2):72-80. PubMed ID: 28374697 [TBL] [Abstract][Full Text] [Related]
11. Depot neuroleptics: side effects and safety. Marder SR J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089 [TBL] [Abstract][Full Text] [Related]
12. Kinematical analysis of motor function in schizophrenic patients: a possibility to separate negative symptoms from extrapyramidal dysfunction induced by neuroleptics? Henkel V; Mergl R; Schäfer M; Rujescu D; Möller HJ; Hegerl U Pharmacopsychiatry; 2004 May; 37(3):110-8. PubMed ID: 15138894 [TBL] [Abstract][Full Text] [Related]
13. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo. Klemp M; Tvete IF; Skomedal T; Gaasemyr J; Natvig B; Aursnes I J Clin Psychopharmacol; 2011 Dec; 31(6):698-704. PubMed ID: 22020356 [TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses. Cesková E; Svestka J Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306 [TBL] [Abstract][Full Text] [Related]
15. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes. Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584 [TBL] [Abstract][Full Text] [Related]
16. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness. Honer WG; Kopala LC; Rabinowitz J J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513 [TBL] [Abstract][Full Text] [Related]
17. Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers. Christoffersen CL; Meltzer LT Neuropsychopharmacology; 1998 May; 18(5):399-402. PubMed ID: 9536454 [TBL] [Abstract][Full Text] [Related]
18. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol. Altamura AC; Buccio M; Colacurcio F; Colombo G; Terzi A Acta Neurol (Napoli); 1986 Feb; 8(1):19-26. PubMed ID: 3962752 [No Abstract] [Full Text] [Related]
19. Adverse effects of risperidone and haloperidol treatment in schizophrenia. Yen YC; Lung FW; Chong MY Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):285-90. PubMed ID: 14751424 [TBL] [Abstract][Full Text] [Related]
20. Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics. Weisbard JJ; Pardo M; Pollack S Psychopharmacol Bull; 1997; 33(1):119-22. PubMed ID: 9133762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]